Back to Search
Start Over
Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion.
- Source :
-
Journal of neurotrauma [J Neurotrauma] 2009 Dec; Vol. 26 (12), pp. 2257-67. - Publication Year :
- 2009
-
Abstract
- An important but poorly understood feature of traumatic brain injury (TBI) is the clinically serious problem of spatiotemporal progression ("blossoming") of a hemorrhagic contusion, a phenomenon we term progressive secondary hemorrhage (PSH). Molecular mechanisms of PSH are unknown and efforts to reduce it by promoting coagulation have met with equivocal results. We hypothesized that PSH might be due to upregulation and activation of sulfonylurea receptor 1 (SUR1)-regulated NC(Ca-ATP) channels in capillary endothelial cells, predisposing to oncotic death of endothelial cells and catastrophic failure of capillary integrity. Anesthetized adult male rats underwent left parietal craniectomy for induction of a focal cortical contusion. The regulatory subunit of the channel, SUR1, was prominently upregulated in capillaries of penumbral tissues surrounding the contusion. In untreated rats, PSH was characterized by progressive enlargement of the contusion deep into the site of cortical impact, including corpus callosum, hippocampus, and thalamus, by progressive accumulation of extravasated blood, with a doubling of the volume during the first 12 h after injury, and by capillary fragmentation in penumbral tissues. Block of SUR1 using low-dose (non-hypoglycemogenic) glibenclamide largely eliminated PSH and capillary fragmentation, and was associated with a significant reduction in the size of the necrotic lesion and in preservation of neurobehavioral function. Antisense oligodeoxynucleotide against SUR1, administered after injury, reduced both SUR1 expression and PSH, consistent with a requirement for transcriptional upregulation of SUR1. Our findings provide novel insights into molecular mechanisms responsible for PSH associated with hemorrhagic contusions, and point to SUR1 as a potential therapeutic target in TBI.
- Subjects :
- ATP-Binding Cassette Transporters antagonists & inhibitors
ATP-Binding Cassette Transporters genetics
Animals
Blood-Brain Barrier metabolism
Blood-Brain Barrier pathology
Blood-Brain Barrier physiopathology
Brain pathology
Brain physiopathology
Brain Hemorrhage, Traumatic pathology
Brain Hemorrhage, Traumatic physiopathology
Brain Injuries pathology
Brain Injuries physiopathology
Calcium Channels metabolism
Disease Models, Animal
Down-Regulation genetics
Down-Regulation physiology
Endothelial Cells metabolism
Glyburide pharmacology
Hypoglycemic Agents pharmacology
Male
Neuroprotective Agents pharmacology
Oligodeoxyribonucleotides, Antisense pharmacology
Potassium Channels, Inwardly Rectifying antagonists & inhibitors
Potassium Channels, Inwardly Rectifying genetics
Rats
Rats, Long-Evans
Receptors, Drug antagonists & inhibitors
Receptors, Drug genetics
Sulfonylurea Receptors
Up-Regulation physiology
ATP-Binding Cassette Transporters metabolism
Brain metabolism
Brain Hemorrhage, Traumatic metabolism
Brain Injuries metabolism
Potassium Channels, Inwardly Rectifying metabolism
Receptors, Drug metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1557-9042
- Volume :
- 26
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Journal of neurotrauma
- Publication Type :
- Academic Journal
- Accession number :
- 19604096
- Full Text :
- https://doi.org/10.1089/neu.2009.1021